Patents Assigned to Jenny Ja Antti Wihurin Rahasto
  • Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
    Patent number: 8415324
    Abstract: Heparin-like compounds inhibit collagen-induced platelet aggregation in flowing whole blood. The compounds share properties displayed by native mast-cell derived heparin proteoglycans (HEP-PG) and/or heparin glycosaminoglycan (HEP-GAG) molecules. The compounds are useful in prevention and treatment of severe vascular disorders including arterial thrombosis.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 9, 2013
    Assignee: Jenny Ja Antti Wihurin Rahasto
    Inventors: Riitta Lassila, Petri Kovanen, Ken Lindstedt
  • HEPARIN-LIKE COMPOUNDS, THEIR PREPARATION AND USE TO PREVENT ARTERIAL THROMBOSIS ASSOCIATED WITH VASCULAR INJURY AND INTERVENTIONS
    Publication number: 20090202607
    Abstract: Heparin-like compounds inhibit collagen-induced platelet aggregation in flowing whole blood. The compounds share properties displayed by native mast-cell derived heparin proteoglycans (HEP-PG) and/or heparin glycosaminoglycan (HEP-GAG) molecules. The compounds are useful in prevention and treatment of severe vascular disorders including arterial thrombosis.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 13, 2009
    Applicant: JENNY JA ANTTI WIHURIN RAHASTO
    Inventors: Riitta Lassila, Petri Kovanen, Ken Lindstedt
  • Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
    Patent number: 7504113
    Abstract: The present invention is related to heparin-like compounds characterized by their capacity of inhibiting collagen-induced platelet aggregation in flowing whole blood and their use for prophylactic treatment of arterial thrombosis associated with vascular or microvascular injury and interventions. Said properties are related to a high coupling density of negatively charged heparin or heparin-like glycosaminoglycan molecules, present in multiple heparin or heparin-like glycosaminoglycans as well as in proteoglycans containing said multiple heparin or heparin-like glycosaminoglycans or lower-molecular-weight heparin or heparin-like glycosaminoglycans connected directly or through spacer/linker molecules to globular core molecules. Heparin-like compounds, with said properties are obtainable from mammalian mast cells, by tissue extraction or cell cultivation.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: March 17, 2009
    Assignee: Jenny Ja Antti Wihurin Rahasto
    Inventors: Riitta Lassila, Petri Kovanen, Ken Lindstedt
  • Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
    Publication number: 20080014239
    Abstract: The present invention is related to heparin-like compounds characterized by their capacity of inhibiting collagen-induced platelet aggregation in flowing whole blood and their use for prophylactic treatment of arterial thrombosis associated with vascular or microvascular injury and interventions. Said properties are related to a high coupling density of negatively charged heparin or heparin-like glycosaminoglycan molecules, present in multiple heparin or heparin-like glycosaminoglycans as well as in proteoglycans containing said multiple heparin or heparin-like glycosaminoglycans or lower-molecular-weight heparin or heparin-like glycosaminoglycans connected directly or through spacer/linker molecules to globular core molecules. Heparin-like compounds, with said properties are obtainable from mammalian mast cells, by tissue extraction or cell cultivation.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 17, 2008
    Applicant: JENNY JA ANTTI WIHURIN RAHASTO
    Inventors: Riitta Lassila, Petri Kovanen, Ken Lindstedt
  • Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
    Publication number: 20030212042
    Abstract: The present invention is related to heparin-like compounds characterized by their capacity of inhibiting collagen-induced platelet aggregation in flowing whole blood and their use for prophylactic treatment of arterial thrombosis associated with vascular or microvascular injury and interventions. Said properties are related to a high coupling density of negatively charged heparin or heparin-like glycosaminoglycan molecules, present in multiple heparin or heparin-like glycosaminoglycans as well as in proteoglycans containing said multiple heparin or heparin-like glycosaminoglycans or lower-molecular-weight heparin or heparin-like glycosaminoglycans connected directly or through spacer/linker molecules to globular core molecules. Heparin-like compounds, with said properties are obtainable from mammalian mast cells, by tissue extraction or cell cultivation.
    Type: Application
    Filed: April 18, 2003
    Publication date: November 13, 2003
    Applicant: JENNY JA ANTTI WIHURIN RAHASTO
    Inventors: Riitta Lassila, Petri Kovanen, Ken Lindstedt